Svizera Labs Private Limited — Pyrazinamide Exporter Profile
Indian Pharmaceutical Exporter · #5 for Pyrazinamide · $1.9M export value · DGFT Verified
Svizera Labs Private Limited is the #5 Indian exporter of Pyrazinamide with $1.9M in export value and 39 verified shipments. Svizera Labs Private Limited holds a 0.2% market share in Pyrazinamide exports across 12 countries. The company exports 5 pharmaceutical products worth $13.7M across 3 therapeutic categories.
Svizera Labs Private Limited — Pyrazinamide Export Profile: Buyers & Destinations
Where Does Svizera Labs Private Limited Export Pyrazinamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $850.0K | 17 | 53.5% |
| VENEZUELA | $181.4K | 4 | 11.4% |
| NEPAL | $150.0K | 3 | 9.4% |
| NAMIBIA | $53.8K | 2 | 3.4% |
| TANZANIA | $50.0K | 1 | 3.1% |
| COLOMBIA | $50.0K | 1 | 3.1% |
| MYANMAR | $50.0K | 1 | 3.1% |
| CONGO | $50.0K | 1 | 3.1% |
| SUDAN | $50.0K | 1 | 3.1% |
| NICARAGUA | $45.0K | 1 | 2.8% |
Svizera Labs Private Limited exports Pyrazinamide to 12 countries. The largest destination is NIGERIA accounting for 53.5% of Svizera Labs Private Limited's Pyrazinamide shipments, followed by VENEZUELA (11.4%) and NEPAL (9.4%). These destinations reflect Svizera Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pyrazinamide from Svizera Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR LABARAN SHEHU | NIGERIA | $550.0K | 11 |
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $300.0K | 6 |
| TO THE ORDER OF | NEPAL | $150.0K | 3 |
| MAR?A LISSETT GARC?A ROBLES | VENEZUELA | $131.4K | 3 |
| MOH- NATIONAL TB AND LEPROSY PROGR | TANZANIA | $50.0K | 1 |
| MINISTERIO DE SALUD Y PROTECCION S | COLOMBIA | $50.0K | 1 |
| MARIA LISSETT GARCIA ROBLES PROCUR | VENEZUELA | $50.0K | 1 |
| ERF. 492, DANTE STREET | NAMIBIA | $50.0K | 1 |
| UNOPS | MYANMAR | $50.0K | 1 |
| COUNTRY REPUBLIQUE DU CONGO | CONGO | $50.0K | 1 |
Svizera Labs Private Limited supplies Pyrazinamide to 18 buyers globally. The largest buyer is DR LABARAN SHEHU (NIGERIA), followed by NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) and TO THE ORDER OF (NEPAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pyrazinamide Export Value and How Much Does Svizera Labs Private Limited Contribute?
India exported $50.2M worth of Pyrazinamide through 1,459 shipments from 90 suppliers to 131 countries, serving 434 buyers globally. Svizera Labs Private Limited contributes $1.9M to this total, accounting for 0.2% of India's Pyrazinamide exports. Svizera Labs Private Limited ships Pyrazinamide to 12 countries through 18 buyers.
What Is the Average Shipment Value for Svizera Labs Private Limited's Pyrazinamide Exports?
Svizera Labs Private Limited's average Pyrazinamide shipment value is $50.0K per consignment, based on 39 shipments totaling $1.9M. The largest destination is NIGERIA (53.5% of Svizera Labs Private Limited's Pyrazinamide exports).
How Does Svizera Labs Private Limited Compare to Other Indian Pyrazinamide Exporters?
Svizera Labs Private Limited ranks #5 among 90 Indian Pyrazinamide exporters with a 0.2% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($18.1M), LUPIN LIMITED ($16.1M), MACLEODS PHARMACEUTICALS LIMITED ($7.2M). Svizera Labs Private Limited processed 39 shipments to 12 destination countries.
What Pyrazinamide Formulations Does Svizera Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150MG/ISONIAZID 75 MG/ PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6431X6) | $300.0K | 6 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABS,EACH CARTON OF 24X28 TABS | $150.0K | 3 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6430x6 | $150.0K | 3 |
| RIFAMPICIN 150 MG/ ISONIAZID 75 MG / PYRAZINAMIDE 400MG / ETHAMBUTOL HCL 275MG TABLETS (QTY. 6430X6 = 38580 STRIPS) | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24x28 TABS | $125.7K | 5 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6431x6= | $100.0K | 2 |
| RIFAMPICIN 150MG ISONIAZID 75MG PYRAZINAMIDE 400MG ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24x28 TABS | $100.0K | 2 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS | $81.4K | 2 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24X28 TABS | $50.0K | 1 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24x28 TABS ( | $50.0K | 1 |
Svizera Labs Private Limited exports 20 distinct Pyrazinamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150MG/ISONIAZID 75 with 6 shipments worth $300.0K.
Regulatory Requirements: Exporting Pyrazinamide to Key Markets
What Svizera Labs Private Limited must comply with to export Pyrazinamide to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Svizera Labs Private Limited Compare to Nearest Pyrazinamide Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MACLEODS PHARMACEUTICALS LIMITED | $7.2M | 143 | 51 | $50.0K |
| 4 | MANEESH PHARMACEUTICALS LIMITED | $3.5M | 69 | 24 | $50.0K |
| 5 | SVIZERA LABS PRIVATE LIMITED ★ | $1.9M | 39 | 12 | $50.0K |
| 6 | MICRO LABS LIMITED | $1.8M | 64 | 23 | $27.7K |
| 7 | MANEESH PHARMACEUTICALS LTD | $400.0K | 8 | 5 | $50.0K |
Svizera Labs Private Limited ranks #5 among 90 Indian Pyrazinamide exporters. Average shipment value of $50.0K compared to the market average of $557.3K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and MANEESH PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Pyrazinamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 11.7% |
| DELHI AIR | 154 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 126 | 8.6% |
| Bombay Air | 94 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 87 | 6.0% |
| JNPT | 87 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 81 | 5.6% |
What Other Tuberculosis Medications Products Does Svizera Labs Private Limited Export?
Svizera Labs Private Limited also exports these tuberculosis medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Svizera Labs Private Limited's Pyrazinamide Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Svizera Labs. The escalation of conflicts in the Middle East, particularly the 2026 Strait of Hormuz crisis, has led to significant disruptions in vital trade corridors. Shipping routes through the Red Sea and the Suez Canal have been compromised, resulting in longer transit times and increased freight costs. For instance, diversions around the Cape of Good Hope have added 10–20 days to transit times and raised freight rates by 40–50% on key India–Europe routes. (livemint.com) These disruptions pose logistical challenges for time-sensitive pharmaceutical shipments, potentially affecting Svizera's export efficiency and cost structures.
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to expand their footprint in markets seeking alternative suppliers. Svizera Labs can capitalize on this shift by strengthening its presence in regions looking to diversify their pharmaceutical import sources. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains imperative. The FMD mandates stringent serialization and traceability requirements, necessitating investments in technology and processes to ensure compliance and maintain access to the lucrative EU market.
Svizera Labs Private Limited — Regulatory Compliance & Quality Standards
The regulatory environment for pharmaceutical exports is becoming increasingly stringent, with agencies like the U.S. Food and Drug Administration (FDA), WHO, and the European Medicines Agency (EMA) enforcing rigorous Good Manufacturing Practice (GMP) standards. Svizera Labs' previous suspension by the WHO in 2016 highlights the critical importance of maintaining compliance with these standards. The successful lifting of the suspension in 2018 demonstrates the company's commitment to quality improvement. Continuous adherence to evolving regulatory requirements is essential for sustaining market access and competitiveness.
About Svizera Labs Private Limited
Svizera Labs Private Limited exports 5 products worth $13.7M. Beyond Pyrazinamide, top products include Rifampicin, Isoniazid, Ethambutol, Strip. View the complete Svizera Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrazinamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Svizera Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 39 individual customs records matching Svizera Labs Private Limited exporting Pyrazinamide, covering 20 formulations to 12 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 434+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pyrazinamide Export Data from Svizera Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Svizera Labs Private Limited's Pyrazinamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Svizera Labs Private Limited
Full Company Profile →
5 products · $13.7M total trade · 3 categories
Pyrazinamide Stats
Company Overview
Top Products by Svizera Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Svizera Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrazinamide. For current shipment-level data, contact TransData Nexus.